EGFR and non-small cell lung carcinoma: In the present study we address two essential questions: first, the incidence of activating EGFR mutations in NSCLC metastases to the CNS, and second, the level of concordance between highly sensitive molecular methods routinely used for EGFR molecular diagnostics in primary lung tumours.